Report finds Ireland among the last to access new medicines in Europe

Report finds Ireland among the last to access new medicines in Europe

Irish cancer patients are among the last in Europe to get access to new medicines.

That is part of the findings of a new report from the Irish Pharmaceutical Healthcare Association.

The IPHA describes the approval of new medicines in Ireland as "frustratingly slow".

Director of Communications at the IPHA, Bernard Mallee, says lack of certainty over funding is the biggest problem.

Mr Mallee said: "There's isn't a predictability around the funding envelope that's available for innovative medicines.

"And while the industry is delivering huge savings, we are not seeing those savings invested back into the availability of medicines for Irish patients.

"This is causing some uncertainty in terms of when we can get access to those medicines and what the outcomes for patients might be."

More on this topic

Over 700 cases of mumps reported in Dublin so far in 2019Over 700 cases of mumps reported in Dublin so far in 2019

Study suggests many heart attack survivors being reckless about health despite warningStudy suggests many heart attack survivors being reckless about health despite warning

Billy Connolly shares update on Parkinson’s diseaseBilly Connolly shares update on Parkinson’s disease

Johnson & Johnson in $4bn opioid offerJohnson & Johnson in $4bn opioid offer


More in this Section

President Higgins and Defence Minister evacuated from hotel in Lebanese capitalPresident Higgins and Defence Minister evacuated from hotel in Lebanese capital

Gardaí appeal for help in search for missing man in GalwayGardaí appeal for help in search for missing man in Galway

Probe launched as Fianna Fail TD claims colleague voted for him in DailProbe launched as Fianna Fail TD claims colleague voted for him in Dail

Taoiseach: All 27 EU states will need to approve any Brexit extension requestsTaoiseach: All 27 EU states will need to approve any Brexit extension requests


Lifestyle

Ovarian cancer has been dubbed ‘the silent killer’. Christina Henry tells Rowena Walsh why she is one of the lucky onesAgeing with attitude: Life after ovarian cancer

More From The Irish Examiner